<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">R. Vanhoof</style></author><author><style face="normal" font="default" size="100%">Gordts,B.</style></author><author><style face="normal" font="default" size="100%">Coignau,H.</style></author><author><style face="normal" font="default" size="100%">Stas,G.</style></author><author><style face="normal" font="default" size="100%">Butzler,J.P.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The in-vitro activity of ceftazidime: comparison with other beta-lactam antibiotics36601</style></title><secondary-title><style face="normal" font="default" size="100%">J.Antimicrob.Chemother.</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">0</style></keyword><keyword><style  face="normal" font="default" size="100%">Activity</style></keyword><keyword><style  face="normal" font="default" size="100%">Agent</style></keyword><keyword><style  face="normal" font="default" size="100%">Agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Ampicillin</style></keyword><keyword><style  face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Antibiotic</style></keyword><keyword><style  face="normal" font="default" size="100%">antibiotics</style></keyword><keyword><style  face="normal" font="default" size="100%">article</style></keyword><keyword><style  face="normal" font="default" size="100%">bacteria</style></keyword><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">beta-Lactams</style></keyword><keyword><style  face="normal" font="default" size="100%">Brussels</style></keyword><keyword><style  face="normal" font="default" size="100%">Cefazolin</style></keyword><keyword><style  face="normal" font="default" size="100%">Cefotaxime</style></keyword><keyword><style  face="normal" font="default" size="100%">Ceftazidime</style></keyword><keyword><style  face="normal" font="default" size="100%">Cephalothin</style></keyword><keyword><style  face="normal" font="default" size="100%">Comparative Study</style></keyword><keyword><style  face="normal" font="default" size="100%">Comparison</style></keyword><keyword><style  face="normal" font="default" size="100%">drug effects</style></keyword><keyword><style  face="normal" font="default" size="100%">general</style></keyword><keyword><style  face="normal" font="default" size="100%">Gram-Negative Bacteria</style></keyword><keyword><style  face="normal" font="default" size="100%">Gram-Positive Bacteria</style></keyword><keyword><style  face="normal" font="default" size="100%">Haemophilus</style></keyword><keyword><style  face="normal" font="default" size="100%">Haemophilus influenzae</style></keyword><keyword><style  face="normal" font="default" size="100%">im</style></keyword><keyword><style  face="normal" font="default" size="100%">Institute</style></keyword><keyword><style  face="normal" font="default" size="100%">invitro</style></keyword><keyword><style  face="normal" font="default" size="100%">IS</style></keyword><keyword><style  face="normal" font="default" size="100%">journal</style></keyword><keyword><style  face="normal" font="default" size="100%">Microbial Sensitivity Tests</style></keyword><keyword><style  face="normal" font="default" size="100%">Moxalactam</style></keyword><keyword><style  face="normal" font="default" size="100%">Oxacillin</style></keyword><keyword><style  face="normal" font="default" size="100%">pharmacology</style></keyword><keyword><style  face="normal" font="default" size="100%">Print</style></keyword><keyword><style  face="normal" font="default" size="100%">SB - IM</style></keyword><keyword><style  face="normal" font="default" size="100%">study</style></keyword><keyword><style  face="normal" font="default" size="100%">values</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">1981</style></year><pub-dates><date><style  face="normal" font="default" size="100%">0/9/1981</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">66</style></number><volume><style face="normal" font="default" size="100%">8 Suppl B</style></volume><pages><style face="normal" font="default" size="100%">63 - 66</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">We have compared the in-vitro bacteriostatic and bactericidal activity of ceftazidime against cephalothin-resistant Gram-negative bacteria, Haemophilus influenzae and Gram-positive bacteria. Comparison was made with cefaperazone, cefuroxime, moxalactam, cefotaxime, cefamandole, cefoxitin, cephalothin, cefazolin, azlocillin, carbenicillin, ticarcillin, ampicillin and oxacillin. In general ceftazidime was one of the most active compounds with low MIC and MBC values</style></abstract><custom1><style face="normal" font="default" size="100%">38437</style></custom1><section><style face="normal" font="default" size="100%">63</style></section></record></records></xml>